University Hospital Zurich

What University Hospital Zurich does

University Hospital Zurich (Universitätsspital Zürich, USZ) is one of Switzerland's largest and oldest university hospitals, founded in 1833 and operated as a public entity under the Canton of Zurich. It runs approximately 900 licensed beds across five locations — the Rämistrasse main campus, an Airport Health Center, and outpatient/imaging sites in Schlieren, Wollishofen, and Stettbach — delivering nearly 300,000 patient care days and ~2,500 births annually. USZ employs over 10,000 staff from approximately 90 countries, including roughly 2,500 researchers, and is consistently ranked among the global top 10 hospitals (Newsweek Best Hospitals 2024).

Its service portfolio spans more than 40 departments and institutes covering emergency medicine 24/7, oncology, cardiology, neurology, transplantation, obesity, pediatrics, and complex specialty surgery. Technology is anchored in robotic surgery systems, AI-assisted diagnostics, comprehensive imaging (MRI, CT, PET), and an emerging AI stack including digital-twin cardiac modeling and predictive oncology models. Recent launches include Donanemab for early-stage Alzheimer's disease, the STARS DAPT Abluminus stent trial, the NAIPO national AI cancer initiative, and clinical translation of epigenetic BET-inhibitor therapy.

USZ's revenue model combines patient services reimbursed under SwissDRG (inpatient) and TARMED (outpatient) across basic, semi-private, and private insurance tiers, supplemented by Canton of Zurich subsidies, competitive research grants (Swiss National Science Foundation, EU frameworks), and donations. Its dedicated International Office serves foreign patients seeking specialized care. Strategic academic partnerships with the University of Zurich, ETH Zurich, and Wyss Zurich, together with international research ties (University of Liverpool, University of Pisa, Leducq Foundation), embed USZ in Switzerland's translational medicine ecosystem. A 2026 investigation into excess mortality in the Cardiac Surgery Clinic (2016-2020) is an active governance and reputational item, though the hospital states quality has recovered under subsequent leadership.

Name

University Hospital Zurich

Legal name

Universitätsspital Zürich

Website

https://usz.ch

Company type

Private

Founded year

1833

Operating status

Operating

Headcount range

251–500 employees

Short description

University Hospital Zurich (USZ) is a public university hospital owned by the Canton of Zurich, operating ~900 beds across five locations with 10,000+ staff, serving Swiss residents and international patients across 40+ specialties. It combines clinical care, translational research with the University of Zurich and ETH Zurich, and emerging AI applications in diagnostics and oncology.

Ownership category

akta.pro rank

Product category

Academic Hospital Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

akta.pro secondary industry

Community & Regional General Hospitals (HLAFAAAB)

Keywords

• University hospital services
• Specialized medical care
• Emergency medical services
• Clinical research programs
• Translational medicine

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue from medical services provided to patients covered by Swiss health insurance (basic, semi-private, and private insurance classes) and international patients.
2. Cantonal Government Funding: Subsidies and funding from the Canton of Zurich supporting the public hospital mandate and infrastructure.
3. Research Grants: Competitive research funding from Swiss National Science Foundation, European Union frameworks, and private foundations supporting clinical and translational research.
4. Donations and Endowments: Charitable contributions from individuals and foundations supporting specific research programs, equipment, and patient care initiatives.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Core offering

University Hospital Zurich operates as a public university hospital delivering comprehensive inpatient, outpatient, and 24/7 emergency medical services across more than 40 medical departments and institutes, ranging from basic care to individualized specialty medicine at international level. It provides advanced treatment programs including cancer care, cardiac surgery, neurosurgery, transplant medicine, memory and obesity clinics, and pioneering therapies, while conducting clinical and translational research in close partnership with the University of Zurich and ETH Zurich.

Product overview

University Hospital Zurich (USZ) operates as Switzerland's leading university hospital offering a comprehensive portfolio of medical services spanning basic care to cutting-edge specialized treatments. The hospital functions as a multi-site medical center with facilities at USZ Campus, Flughafen (Airport), Schlieren, Wollishofen, and Stettbach locations. Key products and services include: Donanemab (Kisunla) Alzheimer's therapy, Stockholm3 prostate cancer genetic test, melanoma immunotherapy treatments, deep brain stimulation for Parkinson's, sirolimus-coated balloon angioplasty (SirPAD), and ultrasound-facilitated thrombolysis for pulmonary embolism. The hospital also participates in research collaborations including epigenetic therapy development, Enzian Pharmaceutics extended-release pill technology, and participates in the NAIPO Swiss AI cancer treatment initiative. USZ offers specialized centers including the Memory Clinic, Skin Tumor Center, Comprehensive Cancer Center Zurich, and various specialized treatment programs.

Differentiator

Problem solved

Functional benefit

Brands

• Comprehensive Cancer Center Zürich (CCCZ): Oncology center at USZ providing cancer treatment and research services
• Hauttumorzentrum
• Zentrum für Essstörungen (ZES)
• Adipositas Zentrum Zürich
• Herzzentrum
• Memory Clinic
• Transplantationszentrum
• International Office

Products and services

• Donanemab (Kisunla) Alzheimer's Treatment Antibody therapy targeting amyloid plaques in the brain, approved by Swissmedic for treatment of early-stage Alzheimer's disease, available at the USZ Memory Clinic to slow cognitive decline in patients with mild cognitive impairment or mild dementia.
• Stockholm3 Prostate Cancer Genetic Test Innovative genetic blood test for early detection of prostate cancer offered as part of preventive care consultations at USZ, providing advanced screening beyond traditional prostate cancer detection methods.
• Abluminus NP Polymer-Free Drug-Eluting Stent Polymer-free drug-eluting stent designed for faster vascular healing and potentially reduced dual antiplatelet therapy duration, available at USZ within the STARS DAPT clinical trial for STEMI patients.
• Melanoma Immunotherapy Treatment Modern immunotherapy treatments for melanoma (black skin cancer) including Nivolumab and Pembrolizumab standard therapies, combined immunotherapies for metastatic melanoma, and BRAF/MEK inhibitors for patients with BRAF gene mutations.
• Sirolimus-Coated Balloon Angioplasty (SirPAD) Sirolimus-coated balloon catheter treatment for peripheral arterial disease (PAD/PAVK) demonstrated to reduce major amputations and emergency surgeries compared to uncoated balloons; results published in the New England Journal of Medicine.
• Ultrasound-Facilitated Catheter-Directed Thrombolysis Combined therapy using blood thinners plus ultrasound-accelerated catheter-directed clot dissolution for intermediate-risk pulmonary embolism, demonstrated in the HI-PEITHO study to reduce mortality, circulatory collapse, and recurrent embolism compared to blood thinners alone.
• Deep Brain Stimulation (DBS) Surgical treatment for Parkinson's disease where electrodes are implanted in the brain to reduce motor symptoms; at USZ, eligible patients can reduce or eliminate Parkinson medications after successful DBS surgery.
• Obesity Treatment Program Comprehensive obesity treatment following new Swiss guidelines emphasizing health and quality of life over weight loss, including lifestyle interventions, modern medications (including weight loss injections), and bariatric surgeries such as gastric bypass or sleeve gastrectomy.
• World's First Reconstructive Lymphatic Surgery Microsurgery on the central lymphatic system performed using a microsurgery robot, executed as a world-first procedure at University Hospital Zurich.
• Aortic Replacement for High-Risk Patients New surgical approach using a vascular prosthesis enabling aortic replacement for previously inoperable high-risk patients, performed at USZ.
• Hantavirus (Andes Strain) Treatment Specialized treatment for Andes strain hantavirus, the only known hantavirus capable of human-to-human transmission; USZ treated a Swiss patient evacuated from the MV Hondius cruise ship outbreak.
• Comprehensive Cancer Center Zürich (CCCZ) Oncology center at USZ providing interdisciplinary cancer treatment and research services, including specialized skin tumor and hematology programs.
• Herzzentrum (Heart Center) Heart center providing comprehensive cardiac care including cardiology and cardiac surgery services at University Hospital Zurich.
• Transplantationszentrum (Transplantation Center) Transplantation center performing organ transplants including lung, liver, and other organs at University Hospital Zurich.
• 24/7 Emergency Medical Services Round-the-clock emergency medical services across multiple specialties including general emergency medicine, cardiac, neurological, vascular, dermatology, eye, ENT, gynecology, and stroke emergencies.
• International Patient Services Dedicated International Office coordinating appointments, travel arrangements, multilingual support, and care delivery for patients traveling from abroad seeking specialized treatment at USZ.

Quantifiable outcome

• Top 10 hospital globally according to Newsweek Best Hospitals ranking
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• University of ZurichcoreStrategic or Co-development PartnerPrimary academic partner providing medical education and conducting joint clinical research. Medical students from University of Zurich train at USZ, and faculty collaborate on translational research projects bridging laboratory discoveries to clinical applications.
• ETH ZurichcoreStrategic or Co-development PartnerLeading technical university partnership for biomedical engineering, computational medicine, and health technology research. Collaboration includes joint research projects, technology transfer, and innovation initiatives in medical technology and digital health.
• University of LiverpoolminorStrategic or Co-development PartnerInternational research collaboration on hearing aid technology and auditory research, involving clinical studies and patient outcome assessments.
• University of PisaminorStrategic or Co-development PartnerCollaborative research partnership on epigenetic drugs and cancer therapeutics, involving joint studies and scientific exchange.
• Kantonsspital Winterthur (KSW)minorStrategic or Co-development PartnerRegional hospital partnership for procurement collaboration and shared services, leveraging combined purchasing power for medical supplies and equipment.
• Wyss ZurichminorStrategic or Co-development PartnerJoint research initiative involving ETH Zurich and University of Zurich focused on translational research in medicine and health technology, with USZ clinical expertise supporting implementation.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cleveland Clinic: U.S. nonprofit academic medical system recognized globally for cardiac and specialty care. Comparable to USZ on clinical reputation and research depth, with a much broader international network.
• Mayo Clinic: Global leader in specialty care, research, and education with a much larger international footprint. Comparable to USZ as a destination academic medical center, but materially larger and privately governed.
• Johns Hopkins Hospital: Premier U.S. academic medical center with deep research output and global brand. Comparable to USZ on translational research and specialty care leadership, with a substantially larger international footprint.

Direct peers

• Inselspital, Bern University Hospital: Swiss university hospital with similar public ownership model, comprehensive specialty offering, and academic affiliation with the University of Bern. Most direct domestic peer to USZ.
• Vienna General Hospital (AKH Wien): Austrian university hospital jointly operated with the Medical University of Vienna. Comparable to USZ in public-sector academic medicine, research intensity, and broad specialty coverage.
• Karolinska University Hospital: Swedish academic medical center affiliated with Karolinska Institutet, providing highly specialized care and translational research. Directly comparable to USZ as a publicly funded, research-intensive university hospital in Northern Europe.
• Geneva University Hospitals (HUG): Largest university hospital in Switzerland, operated by the Canton of Geneva. Comparable to USZ in public mandate, comprehensive specialty mix, and academic research integration.
• University Hospital Heidelberg: German university hospital renowned for oncology, cardiology, and translational medicine. Comparable to USZ in academic-medicine positioning, specialty depth, and strong research output.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals and a leading academic medical center. Comparable to USZ in scale, breadth of specialties, integration of research and clinical care, and public ownership structure.
• University Hospital Basel: Swiss university hospital affiliated with the University of Basel, providing tertiary care and clinical research. Closely comparable domestic peer in scale, ownership, and academic orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@universitaetsspitalzuerich-usz
• Facebookfacebook.com/universitaetsspitalzuerich
• LinkedInlinkedin.com/company/universitatsspital-zurich
• Instagraminstagram.com/universitaetsspitalzuerich
• TikTokusz.ch/tiktok
• Xx.com/unispital_usz

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Hospital Zurich